Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

AstraZeneca today announced a strategic regional collaboration with the Middle East North Africa Committee for Treatment and ...

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

Home to 4.8 billion people or 60 percent of the world’s population, Asia accounts for 50 percent of the global cancer ...

AstraZeneca PLC (NASDAQ:AZN), the British pharmaceutical company best known for its COVID-19 drug, was at the center of analyst action on December 9th after a report from TD Cowen.

The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating ...

AstraZeneca's baxdrostat heads into FDA review after Phase 3 data showed strong blood pressure reductions in adults with hard ...

Former NHLer TJ Oshie and his wife Lauren Oshie have partnered with pharmaceutical giant AstraZeneca to raise awareness about ...